Skip to Main Content

Paper Details

Race and risk of subsequent aggressive breast cancer following ductal carcinoma in situ.
Cancer
13
2019
21-gene recurrence, DCIS, ER, ER+, ER+ and, ER-, IBC, IBCs, PR, aggressive, breast cancer, ductal carcinoma in situ, estrogen, estrogen receptor, invasive breast cancer, patients, progesterone, progesterone receptor, women
Author NameAffiliation
Jason D WeberAlvin J. Siteman Cancer Center, Barnes-Jewish Hospital and Washington University School of Medicine
Jason D WeberWashington University School of Medicine
Graham A ColditzWashington University School of Medicine
Graham A ColditzAlvin J. Siteman Cancer Center, Barnes-Jewish Hospital and Washington University School of Medicine
Graham A ColditzWashington University School of Medicine
Graham A ColditzAlvin J. Siteman Cancer Center, Barnes-Jewish Hospital and Washington University School of Medicine
  • 1 - 6

Datasets

Release 1.2